Any current/future new fundraising through debt or equity?

There is no mention of any current or planned fundraising through debt or equity in the provided transcript. The company highlights a strong capital base with a solvency ratio of 2.29 times as of 30th June 2024, well above the regulatory requirement of 1.5 times. There is no discussion of capital raising plans or intentions to issue new equity or debt. Focus is on business growth, profitability, and operational efficiencies rather than on raising external funds.

Future growth expectations in sales/revenue/volumes?

Gross Written Premium (GWP) grew 18% YoY in Q1 FY '25, reaching Rs. 3,476 crore. Retail fresh premium and agent activation grew in the mid-teens. Banca (banking partners) fresh business grew 25%; corporate channel fresh business grew 110%. Digital channel fresh business grew 25%, holding 50% market share in direct-to-consumer space. The ratio of fresh to renewal business improved to 25:75 from 23:77 YoY. Expansion in semi-urban and rural areas with 165 new sales manager stations added; rural agents increased by 30% YoY. Presence in 17,253 PIN codes covering extensive geography. Long-term polic

Future growth expectations in earnings/operating earnings/profits/EPS?

The company expects continued profitable growth with a focus on maintaining healthy business fundamentals. (Page 20) Profit before tax for Q1 FY '25 grew by 11% year-on-year to Rs. 426 crore; PAT also increased by 11% to Rs. 319 crore. (Page 7) The combined ratio for Q1 FY '25 is 99.2%, indicating efficient underwriting and expense management. (Page 7) Investment income grew 18% year-on-year, supporting overall profitability. (Page 7) Expansion in digital channels and bancassurance, along with increased agent network, is expected to fuel growth. (Pages 5-7) Price hikes and product mix adjustme

Star Health InsuQ1 FY25Insurance

Star Health Insu Q1 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹572.9P/E: 32.0Market Cap: ₹33.7K CrSector: Insurance

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

Gross Written Premium (GWP) grew 18% YoY in Q1 FY '25, reaching Rs. 3,476 crore.
Retail fresh premium and agent activation grew in the mid-teens.
Banca (banking partners) fresh business grew 25%; corporate channel fresh business grew 110%.
Digital channel fresh business grew 25%, holding 50% market share in direct-to-consumer space.
The ratio of fresh to renewal business improved to 25:75 from 23:77 YoY.
Expansion in semi-urban and rural areas with 165 new sales manager stations added; rural agents increased by 30% YoY.
Presence in 17,253 PIN codes covering extensive geography.
Long-term policies in retail GWP increased from 5% to 7%.
By FY '28, aim to double GWP to Rs. 30,000 crore and triple PAT to Rs. 2,500 crore.
Strategy: Profitable growth focusing on targeted porting in low-risk regions and customer-centric product offerings.

Margin guidance

Category 3

The company expects continued profitable growth with a focus on maintaining healthy business fundamentals. (Page 20)
Profit before tax for Q1 FY '25 grew by 11% year-on-year to Rs. 426 crore; PAT also increased by 11% to Rs. 319 crore. (Page 7)
The combined ratio for Q1 FY '25 is 99.2%, indicating efficient underwriting and expense management. (Page 7)
Investment income grew 18% year-on-year, supporting overall profitability. (Page 7)
Expansion in digital channels and bancassurance, along with increased agent network, is expected to fuel growth. (Pages 5-7)
Price hikes and product mix adjustments are expected to improve loss ratios and profitability going forward. (Pages 16-20)
The company aims to continue increasing market share and policy retention rates, supporting sustainable profit growth. (Pages 7, 17)
Long-term reinsurance contracts and wellness initiatives will also positively impact expense and claims management. (Pages 9,19)

See what Star Health Insu management said on margin guidance — free account, 30 seconds.

Fundraise plans

There is no mention of any current or planned fundraising through debt or equity in the provided transcript.
The company highlights a strong capital base with a solvency ratio of 2.29 times as of 30th June 2024, well above the regulatory requirement of 1.5 times.
There is no discussion of capital raising plans or intentions to issue new equity or debt.
Focus is on business growth, profitability, and operational efficiencies rather than on raising external funds.

Order book

The provided transcript from the Star Health and Allied Insurance Company Limited earnings call does not mention any details related to current or expected order book or pending orders. The focus is primarily on insurance premium growth, claims ratios, product portfolio, pricing strategies, renewal ratios, distribution channels, and regulatory outlook. There is no information on order book or pending orders, as it is an insurance company transcript dealing with underwriting, claims, and growth metrics rather than order-based business.

See what Star Health Insu management said on order book — free account, 30 seconds.

Capex plans

Yes

- The company is seriously evaluating adjacencies and composite business opportunities to expand into life insurance and general insurance sectors. - They have engaged Boston Consulting Group (BCG) to develop strategies for cross-selling and upselling protection plans, indicating future strategic investments in product innovation and market expansion. - The company is preparing for the eventual rollout of composite licenses by the regulator and aims to be fully ready to participate once such regulations come into force. - Investments are being made in technology and processes to improve customer retention, with more than 50% of customers renewing policies online. - There are ongoing investments in wellness and prevention activities, which are allocated under claims as part of long-term strategic spending. No explicit mention of near-term capital expenditure amounts, but focus is on strategic and capability-building investments to support growth and diversification.

Track Star Health Insu — get its next earnings analysis in your feed

How does Star Health Insu rank vs peers in Insurance?

Pro feature

ThisStar Health Insu

Rev 3Mar 3

See where Star Health Insu sits in InsuranceSee which companies these are, and every other name in the sector.Open rankings

How does Star Health Insu rank in Insurance?

Compare Star Health Insu against every Insurance company (Q1 FY25) on revenue, margins and earnings-call signals.

View Insurance leaderboard →

What Star Health Insu's management said in earlier quarters

Earlier calls (8)

Others in Insurance this season

Niva Bupa Health (Q2 FY27)
Profit after tax for H1 FY27 has risen to INR 273 crores from INR 132 crores YoY, indicating robust profitability momentum. Key concall takeaways from Niva…
Max Financial (Q2 FY27)
Partnership channels (excluding Axis) growing strongly (~19% in Q2 FY27) with new partnerships expanding the ecosystem. Key concall takeaways from Max…
Life Insurance (Q2 FY27)
Protection products are growing rapidly at over 50%, adding to the overall premium growth. Key concall takeaways from Life Insurance Corporation of India's Q2…
Go Digit General (Q2 FY27)
Go Digit is seeing growth opportunities in group health insurance, with potential to grow business by about 5% through pricing improvements. Key concall…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Star Health Insu Q1 FY25 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

How does Star Health Insu rank in Insurance?

Continue your research

What Star Health Insu's management said in earlier quarters

Others in Insurance this season